Meridian Bioscience Preliminary Q2 Revenues Up 14 Percent

Apr 02, 2020

|

NEW YORK – Meridian Bioscience announced on Thursday that its preliminary fiscal Q2 revenues are expected to grow about 14 percent year over year.

For the quarter, the company anticipates revenues of about $57 million, up from $50.2 million in the year-ago quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Open at Publication

Howard Hughes Medical Institute will be requiring its researchers to publish their work so it is immediately accessible to the public, ScienceInsider writes.

Truth and Science

The Huffington Post reports that Francis Collins, the director of the US National Institutes of Health, has urged Americans to recommit to reason.

Quick Tests to Be Given Out

About 150 million rapid coronavirus tests purchased by the US federal government are to be distributed to nursing homes, colleges, and the states, according to the New York Times.

Nature Papers Examine Molecular Pathways in Alzheimer's Disease, Diploid Potato Assembly, More

In Nature this week: multi-omic analysis of Alzheimer's disease brain samples, de novo assembly of a diploid potato, and more.

Menu

Meridian Bioscience Preliminary Q2 Revenues Up 14 Percent

To read the full story....

Breaking News

Genomic Study of Argentinian Cholera Outbreak Finds Differences Between Endemic, Epidemic Bacteria

Amid Volatile Markets, GenomeWeb Index Up 3 Percent in September

Algorithm Uncovers New Complex Rearrangements Classes in Cancer Genomes

Cancer Clues Gleaned from Somatic Mutation Patterns in Normal Bladders

DiamiR Wins $3.9M in NIH Funding for Neurological Disease Diagnostic Development

CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto

The Scan

Open at Publication

Truth and Science

Quick Tests to Be Given Out

Nature Papers Examine Molecular Pathways in Alzheimer's Disease, Diploid Potato Assembly, More

What's Popular?

Sophia Genetics Closes $110M Series F Funding Round

Bruker Acquires Software Platform From Integrated Proteomics Applications

CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto

BioGX BV Gets CE-IVD Mark for Coronavirus, Flu, RSV Combo Test

Quidel Releases Preliminary Q3 Results, Partners with Biodesix for Big Ten Surveillance

Sponsorships